Levi & Korsinsky notifies investors that it has commenced an investigation into Tandem Diabetes Care, Inc. (NASDAQ: TNDM) concerning potential violations of the federal securities laws.
Tandem disclosed on August 7, 2025, that a malfunction had been identified in some of its insulin pumps, which could "trigger an error resulting in a discontinuation of insulin delivery," which "could result in hyperglycemia due to discontinuation of insulin delivery" and "may require hospitalization or intervention from a medical professional." Tandem stated that it had sent notices to impacted customers between July 22 and 24, 2025. Following this news, Tandem's stock price dropped.
If you suffered a loss on your Tandem Diabetes Care, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





